Mercer Capital Advisers, Inc. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Mercer Capital Advisers, Inc. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2021$63,000
-26.7%
3,500
-30.0%
0.03%
-20.9%
Q2 2021$86,000
-14.0%
5,0000.0%0.04%
-20.4%
Q1 2021$100,000
+17.6%
5,0000.0%0.05%
+14.9%
Q4 2020$85,000
+2.4%
5,0000.0%0.05%
-7.8%
Q3 2020$83,000
-28.4%
5,0000.0%0.05%
-31.1%
Q2 2020$116,000
+30.3%
5,0000.0%0.07%
+12.1%
Q1 2020$89,0005,0000.07%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders